X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 55 filers reported holding X4 PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $477,544 | -43.8% | 438,114 | 0.0% | 0.00% | – |
| Q2 2023 | $849,941 | +23.4% | 438,114 | +446.9% | 0.00% | – |
| Q1 2021 | $689,000 | +27.4% | 80,113 | -4.9% | 0.00% | – |
| Q4 2020 | $541,000 | -3.7% | 84,237 | +1.4% | 0.00% | – |
| Q3 2020 | $562,000 | -27.1% | 83,096 | +0.5% | 0.00% | – |
| Q2 2020 | $771,000 | +75.6% | 82,693 | +88.5% | 0.00% | – |
| Q1 2020 | $439,000 | +27.6% | 43,864 | +36.3% | 0.00% | – |
| Q4 2019 | $344,000 | -15.9% | 32,187 | 0.0% | 0.00% | – |
| Q3 2019 | $409,000 | +131.1% | 32,187 | +172.5% | 0.00% | – |
| Q2 2019 | $177,000 | – | 11,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |